Malignant neoplasm treatment protocol
AssigneeNorth Texas Medical Associates
InventorIvan E. Danhof
Life of this patent
Estimating the term…
Abstract
Methods, compositions, and strategies for the treatment of malignant neoplasms are presented herein. The treatment modalities are directed towards exploiting characteristics of cancer cells as well as correcting defective biochemical pathways and systems in the body.
Claims45
A method for treating one or more cancers in a patient comprising a combination of one or more treatment modalities selected from the group consisting of:
- administering a radiation therapy;
- administering a chemotherapy;
- performing a surgical intervention;
- injecting a sterile polymannan extract formulation two to three times a week, wherein the sterile injectable polymannan extract formulation comprises a specified quantity of a very fine polymannan extract dissolved in deionized water and one or more pharmaceutical preservatives;
- administering an alkaline diet by itself or as a supplement along with a regular diet to create an alkaline milieu, maintain an alkaline milieu, or both, wherein the alkaline diet comprises:
- a solution of sodium bicarbonate, one or more alkaline ash forming foods selected from the group consisting of alfalfa sprouts, artichokes, broccoli, cantaloupe, celeriac, cranberries, dates, flaxseed, huckleberries, lemons, almonds, apples (apple cider) apricots, bananas, beets, blackberries, blueberries, brussel sprouts, burdock cabbage, carob carrots, cauliflower, celery, chard, cherries, chives, coconut, cucumbers, currants, dandelion greens, dill, dock, endive, figs (dried), garlic, grapefruit, green beans, guava, irish moss, kelp, kohlrabi leeks, lettuce, lima beans, limes, loganberries, loquats, molasses, nectarines, oranges, pears, radishes, rutabagas, squash, vegetable oils, mango, melons, millet mint, mulberries, muskmelon, mustard greens, okra, olives, olive oil, onions, papaya, parsley, parsnips, peaches, persimmons, pineapple, plums, pumpkin, raisins, raspberries, rhubarb, romaine, sea grass, sorrell, soybeans, spinach, strawberries, swisschard, tangerines, turnips, water chestnuts, watercress, and watermelon, and one or more optional flavoring agents, coloring agents, sweeteners, and other organoleptic compounds;
- administering a therapeutically effective amount of a pharmaceutical composition orally or parenterally, wherein the composition comprises:
- a specified quantity of dichloroacetate (DCA) in a solid or liquid dosage form, a specified quantity of alpha lipoic acid (ALA) in a solid or liquid dosage form, and one or more optional pharmaceutically acceptable excipients selected from the group consisting of preservatives, bulking agents, anti adherents, lubricants, sweeteners, and other organoleptic agents;
- and
- administering a nutritional composition comprising:
- Vitamin C (Ascorbic acid, magnesium
- 700
- mg
- ascorbate, calcium ascorbate, and palmitic ascorbate)
- L-Lysine
- 1,000
- mg
- L-Proline
- 750
- mg
- L-Arginine
- 500
- mg
- N-Acetyl Cysteine
- 200
- mg
- Green tea Extract
- 1000
- mg
- Total polyphenols
- 80%
- Catechins
- 60%
- EGCG
- 35%
- Caffeine
- 1%
- Minerals
- Selenium
- 30
- mcg
- Copper
- 2
- mg
- Manganese
- 1
- mg.
An alkaline diet for the treatment of one or more malignancies selected from the group consisting of leukemias and lymphomas, prostate cancer, breast cancer, and colon cancer, and for the treatment of one or more immune disorders comprising:
- a solution of sodium bicarbonate;
- one or more alkaline ash forming foods selected from the group consisting of alfalfa sprouts, artichokes, broccoli, cantaloupe, celeriac, cranberries, dates, flaxseed, huckleberries, lemons, almonds, apples (apple cider) apricots, bananas, beets, blackberries, blueberries, brussel sprouts, burdock cabbage, carob carrots, cauliflower, celery, chard, cherries, chives, coconut, cucumbers, currants, dandelion greens, dill, dock, endive, figs (dried), garlic, grapefruit, green beans, guava, irish moss, kelp, kohlrabi leeks, lettuce, lima beans, limes, loganberries, loquats, molasses, nectarines, oranges, pears, radishes, rutabagas, squash, vegetable oils, mango, melons, millet mint, mulberries, muskmelon, mustard greens, okra, olives, olive oil, onions, papaya, parsley, parsnips, peaches, persimmons, pineapple, plums, pumpkin, raisins, raspberries, rhubarb, romaine, sea grass, sorrell, soybeans, spinach, strawberries, swisschard, tangerines, turnips, water chestnuts, watercress, and watermelon;
- and
- one or more optional flavoring agents, coloring agents, sweeteners, and other organoleptic compounds.
A method of treating a patient suffering from one or more malignancies selected from the group consisting of leukemias and lymphomas, prostate cancer, breast cancer, and colon cancer, one or more immune disorders, or both comprising the steps of:
- identifying an individual in need of treatment against the one or more malignancies, the one or more immune disorders, or both;
- and
- administering an alkaline diet by itself or as a supplement along with a regular diet, wherein the alkaline diet comprises:
- a solution of sodium bicarbonate;
- one or more alkaline ash forming foods selected from the group consisting of alfalfa sprouts, artichokes, broccoli, cantaloupe, celeriac, cranberries, dates, flaxseed, huckleberries, lemons, almonds, apples (apple cider) apricots, bananas, beets, blackberries, blueberries, brussel sprouts, burdock cabbage, carob carrots, cauliflower, celery, chard, cherries, chives, coconut, cucumbers, currants, dandelion greens, dill, dock, endive, figs (dried), garlic, grapefruit, green beans, guava, irish moss, kelp, kohlrabi leeks, lettuce, lima beans, limes, loganberries, loquats, molasses, nectarines, oranges, pears, radishes, rutabagas, squash, vegetable oils, mango, melons, millet mint, mulberries, muskmelon, mustard greens, okra, olives, olive oil, onions, papaya, parsley, parsnips, peaches, persimmons, pineapple, plums, pumpkin, raisins, raspberries, rhubarb, romaine, sea grass, sorrell, soybeans, spinach, strawberries, swisschard, tangerines, turnips, water chestnuts, watercress, and watermelon;
- and
- one or more optional flavoring agents, coloring agents, sweeteners, and other organoleptic compounds.
An injectable solution of sodium bicarbonate for a treatment of one or more malignancies or for maintaining an alkaline milieu in a patient undergoing an alkaline diet treatment for the one or more malignancies comprising:
- a specified quantity of sodium bicarbonate dissolved in deionized water to give a final concentration of 5%;
- and
- one or more pharmaceutically acceptable preservatives.
A method of creating, maintaining an alkaline milieu, or both for the treatment of one or more malignancies selected from the group consisting of leukemias and lymphomas, prostate cancer, breast cancer, and colon cancer, and one or more immune disorders in a patient comprising the steps of:
- identifying an individual in need of treatment against the one or more malignancies;
- and
- injecting intravenously a sterile 5% solution of sodium bicarbonate in deionized water along with one or more pharmaceutical preservatives selected from the group consisting of parabens, benzoic acid and their salts, mercurials, quarternary ammonium salts, benzyl alcohol and other related alcohols, and phenols.
A pharmaceutical composition for preventing or slowing a growth and a proliferation of one or more cancer cells, induction of an apopotosis of the one or more cancer cells or both in a patient comprising:
- a specified quantity of dichloroacetate (DCA) in a solid or liquid dosage form;
- a specified quantity of alpha lipoic acid (ALA) in a solid or liquid dosage form;
- and
- one or more optional pharmaceutically acceptable excipients selected from the group consisting of preservatives, bulking agents, anti adherents, lubricants, sweeteners, and other organoleptic agents.
A method for treating one or more cancers by preventing or slowing a growth and a proliferation of the one or more cancer cells, induction of an apopotosis of the one or more cancer cells, or both in a patient comprising the steps of:
- identifying an individual in need of treatment against the one or more cancers;
- and
- administering a therapeutically effective amount of a pharmaceutical composition orally or parenterally, wherein the composition comprises:
- a specified quantity of dichloroacetate (DCA) in a solid or liquid dosage form;
- a specified quantity of alpha lipoic acid (ALA) in a solid or liquid dosage form;
- and
- one or more optional pharmaceutically acceptable excipients selected from the group consisting of preservatives, bulking agents, anti adherents, lubricants, sweeteners, and other organoleptic agents.
A nutrient composition for preventing angiogenesis, a growth, a proliferation, or both of one or more cancer cells comprising:
- Vitamin C, Vitamin C salts, modifications and derivatives thereof;
- one or more amino acids selected from the group consisting of alanine, arginine, asparagine, aspartic acid, cysteine, glycine, glutamine, glutamic acid, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, tryptophan, threonine, tyrosine, and valine;
- one or more herbal, plant, and animal products comprising tea extracts, catechins, polyphenols, epigaliocatechingallate (EGCG), cardamom, cayenne pepper, ginger, sage, thyme, turmeric, citrus pectin, artemisinin, graviola, carnivora, fish oil (epa+dha), genestein (soybeans), garlic;
- one or more mineral supplements;
- and
- one or more optional additives selected from the group consisting of coloring agents, flavoring agents, sweeteners, preservatives, and other organoleptic agents.
A nutrient composition for preventing angiogenesis, a growth, a proliferation or both of one or more cancer cells comprising:
- Vitamin C (Ascorbic acid, magnesium
- 700
- mg
- ascorbate, calcium ascorbate, and palmitic ascorbate)
- L-Lysine
- 1,000
- mg
- L-Proline
- 750
- mg
- L-Arginine
- 500
- mg
- N-Acetyl Cysteine
- 200
- mg
- Green tea Extract
- 1000
- mg
- Total polyphenols
- 80%
- Catechins
- 60%
- EGCG
- 35%
- Caffeine
- 1%
- Minerals
- Selenium
- 30
- mcg
- Copper
- 2
- mg
- Manganese
- 1
- mg.
A method for treating one or more cancers by preventing angiogenesis, a growth, a proliferation, or both of one or more cancer cells in a patient comprising the steps of:
- identifying the patient in need of treatment against the one or more cancers, wherein the one or more cancers comprise leukemias and lymphomas, prostate cancer, breast cancer, and colon cancer;
- and
- administering a nutritional composition comprising:
- Vitamin C (Ascorbic acid, magnesium
- 700
- mg
- ascorbate, calcium ascorbate, and palmitic ascorbate)
- L-Lysine
- 1,000
- mg
- L-Proline
- 750
- mg
- L-Arginine
- 500
- mg
- N-Acetyl Cysteine
- 200
- mg
- Green tea Extract
- 1000
- mg
- Total polyphenols
- 80%
- Catechins
- 60%
- EGCG
- 35%
- Caffeine
- 1%
- Minerals
- Selenium
- 30
- mcg
- Copper
- 2
- mg
- Manganese
- 1
- mg
- for the prevention of the angiogenesis, the growth, the proliferation or both of one or more cancer cells in the patient.
Dependencies are inferred from the claim text.